The U.S. Food and Drug Administration on Thursday approved UroGen Pharma's drug to treat a type of bladder cancer, providing ...

Rein Therapeutics has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after ...

With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...

WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial ...

The federal government plans to develop a new definition of ultraprocessed foods, a wide-ranging group of snacks, meals and ...

Some medical experts warn that as Ozempic helps overcome food addiction, the junk food industry is adapting with ...

Nearly 1 in 5 positions across the Food and Drug Administration's human food inspection divisions are now vacant, multiple ...

The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...

AI is slowly permeating all corners of the federal government, including the Food and Drug Administration, where, according ...

UroGen Pharma received Food and Drug Administration approval for bladder cancer drug Zusduri, previously known as UGN-102. The company expects the drug will be available on or about July 1. It was ...

As lawmakers eye closing a federal loophole for chemicals added to the U.S. food supply, major food companies have converged ...